OCTAVIA CLOPTON: Open Payments
NPI 1124702121 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Genetix Biotherapeutics Inc | 1 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $56 |
Products named: LYFGENIA, FRUZAQLA, KEYTRUDA.
Industry payments across MD — which companies pay providers there.
